Christi Shaw
Chief Executive Officer, Kite
Christi Shaw serves as Chief Executive Officer of Kite, Gilead's cell therapy company. Based in Santa Monica, California, Kite is pursuing the ambitious goal of a cure for cancer with industry-leading pipeline and manufacturing capabilities. In her role, Christi is responsible for all cell therapy operations around the world.
Before joining Gilead in 2019, Christi held senior executive positions at Eli Lilly & Co. and Novartis Corp. Her leadership has spanned a broad range of therapeutic areas, including oncology.
Christi holds a bachelor's degree in business administration from Iowa State University and an MBA from the University of Wisconsin.
In 2016, she founded the More Moments More Memories Foundation, which assists patients with cancer and their families. Christi currently serves on the board of directors of the Biotechnology Innovation Organization, Avantor and the Healthcare Women's Business Association.
-
Daniel O’Day
Chairman and Chief Executive Officer, Gilead Sciences, Inc.
-
Andrew Dickinson
Chief Financial Officer
-
Flavius Martin
Executive Vice President, Research
-
Jyoti Mehra
Executive Vice President, Human Resources
-
Johanna Mercier
Chief Commercial Officer
-
Merdad Parsey, MD, PhD
Chief Medical Officer
-
Brett A. Pletcher
Executive Vice President, Corporate Affairs and General Counsel
-
Christi Shaw
Chief Executive Officer, Kite
-
Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing